COGT
Cogent Biosciences, Inc.Company with tickers: COGT
CIK
1622229
CUSIP
19240Q201
Shares Outstanding
170,868,004
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-19 | Robbins Andrew R | Director, President and CEO | Gift | 160,000 |
| 2026-05-19 | Robbins Andrew R | Director, President and CEO | Gift | 160,000 |
| 2026-04-01 | Ferrante Karen Jean | Director | Award | 686 |
| 2026-03-31 | Fairmount Funds Management LLC | Director | Sell | 7,000,000 |
| 2026-03-31 | Fairmount Funds Management LLC | Director | Other | 28,000 |
| 2026-03-31 | Fairmount Funds Management LLC | Director | Other | 7,000,000 |
| 2026-01-22 | Fairmount Funds Management LLC | Director | Other | 67,414 |
| 2026-01-22 | Fairmount Funds Management LLC | Director | Sell | 3,500,000 |
| 2026-01-01 | Ferrante Karen Jean | Director | Award | 643 |
| 2025-12-26 | Sachs Jessica | Chief Medical Officer | Sell | 82,642 |
| 2025-12-26 | Robinson John Edward | Chief Scientific Officer | Sell | 90,000 |
| 2025-12-26 | Kearns Evan | Chief Legal Officer | Sell | 65,000 |
| 2025-12-26 | Green John L. | Chief Financial Officer | Sell | 77,000 |
| 2025-12-17 | Robinson John Edward | Chief Scientific Officer | Award | 320,000 |
| 2025-12-17 | Robinson John Edward | Chief Scientific Officer | Award | 50,000 |
| 2025-12-17 | Robinson John Edward | Chief Scientific Officer | Tax | 139,998 |
| 2025-12-17 | Robinson John Edward | Chief Scientific Officer | Award | 65,000 |
| 2025-12-17 | Pinnow Cole | Chief Commercial Officer | Award | 50,000 |
| 2025-12-17 | Pinnow Cole | Chief Commercial Officer | Award | 214,000 |
| 2025-12-17 | Pinnow Cole | Chief Commercial Officer | Award | 65,000 |
| 2025-12-17 | Pinnow Cole | Chief Commercial Officer | Tax | 94,800 |
| 2025-12-17 | Kearns Evan | Chief Legal Officer | Award | 40,000 |
| 2025-12-17 | Kearns Evan | Chief Legal Officer | Award | 55,000 |
| 2025-12-17 | Kearns Evan | Chief Legal Officer | Tax | 125,602 |
| 2025-12-17 | Kearns Evan | Chief Legal Officer | Award | 260,000 |
| 2025-12-17 | Sachs Jessica | Chief Medical Officer | Award | 50,000 |
| 2025-12-17 | Sachs Jessica | Chief Medical Officer | Tax | 154,716 |
| 2025-12-17 | Sachs Jessica | Chief Medical Officer | Award | 65,000 |
| 2025-12-17 | Sachs Jessica | Chief Medical Officer | Award | 320,000 |
| 2025-12-17 | Robbins Andrew R | Director, President and CEO | Award | 245,000 |
| 2025-12-17 | Robbins Andrew R | Director, President and CEO | Award | 185,000 |
| 2025-12-17 | Robbins Andrew R | Director, President and CEO | Tax | 367,497 |
| 2025-12-17 | Robbins Andrew R | Director, President and CEO | Award | 840,000 |
| 2025-12-17 | Green John L. | Chief Financial Officer | Award | 50,000 |
| 2025-12-17 | Green John L. | Chief Financial Officer | Tax | 145,007 |
| 2025-12-17 | Green John L. | Chief Financial Officer | Award | 300,000 |
| 2025-12-17 | Green John L. | Chief Financial Officer | Award | 65,000 |
| 2025-10-01 | Ferrante Karen Jean | Director | Award | 1,642 |
| 2025-07-10 | Fairmount Funds Management LLC | Director | Buy | 2,777,777 |
| 2025-07-01 | Ferrante Karen Jean | Director | Award | 3,314 |
| 2025-06-04 | Ferrante Karen Jean | Director | Award | 44,700 |
| 2025-06-04 | Ros Matthew | Director | Award | 44,700 |
| 2025-06-04 | Harwin Peter Evan | Director | Award | 44,700 |
| 2025-06-04 | CAIN CHRISTOPHER W. | Director | Award | 44,700 |
| 2025-06-04 | Shegog Todd | Director | Award | 44,700 |
| 2025-06-04 | Morris Arlene | Director | Award | 44,700 |
| 2025-04-01 | Ferrante Karen Jean | Director | Award | 3,788 |
| 2025-01-23 | Pinnow Cole | Chief Commercial Officer | Award | 240,000 |
| 2025-01-23 | Robinson John Edward | Chief Scientific Officer | Award | 270,000 |
| 2025-01-23 | Robbins Andrew R | Director, President and CEO | Award | 915,000 |
| 2025-01-23 | Kearns Evan | Chief Legal Officer | Award | 230,000 |
| 2025-01-23 | Green John L. | Chief Financial Officer | Award | 270,000 |
| 2025-01-23 | Sachs Jessica | Chief Medical Officer | Award | 270,000 |
| 2025-01-14 | Pinnow Cole | Chief Commercial Officer | Buy | 43,750 |
| 2025-01-01 | Ferrante Karen Jean | Director | Award | 2,785 |
| 2024-10-01 | Ferrante Karen Jean | Director | Award | 2,034 |
| 2024-07-01 | Ferrante Karen Jean | Director | Award | 2,462 |
| 2024-06-10 | Fairmount Funds Management LLC | Director | Convert | 1,500,000 |
| 2024-06-10 | Fairmount Funds Management LLC | Director | Convert | 1,500 |
| 2024-06-05 | CAIN CHRISTOPHER W. | Director | Award | 44,700 |
| 2024-06-05 | Ros Matthew | Director | Award | 44,700 |
| 2024-06-05 | Ferrante Karen Jean | Director | Award | 44,700 |
| 2024-06-05 | Harwin Peter Evan | Director | Award | 44,700 |
| 2024-06-05 | Shegog Todd | Director | Award | 44,700 |
| 2024-06-05 | Morris Arlene | Director | Award | 44,700 |
| 2024-05-25 | Pinnow Cole | Chief Commercial Officer | Award | 525,000 |
| 2024-05-25 | Pinnow Cole | Chief Commercial Officer | Other | 700 |
| 2024-04-01 | Ferrante Karen Jean | Director | Award | 3,213 |
| 2024-03-28 | Fairmount Funds Management LLC | Director | Other | 11,914 |
| 2024-03-28 | Fairmount Funds Management LLC | Director | Other | 11,914 |
| 2024-03-28 | Fairmount Funds Management LLC | Director | Other | 286,851 |
| 2024-03-28 | Fairmount Funds Management LLC | Director | Other | 286,851 |
| 2024-02-16 | Fairmount Funds Management LLC | Director | Award | 1,500 |
| 2024-02-16 | Fairmount Funds Management LLC | Director | Award | 1,166,666 |
| 2024-02-16 | Fairmount Funds Management LLC | Director | Other | 286,851 |
| 2024-01-23 | Robinson John Edward | Chief Scientific Officer | Award | 300,000 |
| 2024-01-23 | Kearns Evan | Chief Legal Officer | Award | 255,000 |
| 2024-01-23 | Sachs Jessica | Chief Medical Officer | Award | 300,000 |
| 2024-01-23 | Robbins Andrew R | Director, President and CEO | Award | 1,100,000 |
| 2024-01-23 | Green John L. | Chief Financial Officer | Award | 300,000 |
| 2024-01-02 | Ros Matthew | Director | Award | 3,051 |
| 2024-01-02 | Ferrante Karen Jean | Director | Award | 3,298 |
| 2023-10-02 | Ros Matthew | Director | Award | 2,170 |
| 2023-10-02 | Ferrante Karen Jean | Director | Award | 2,345 |
| 2023-07-03 | Ferrante Karen Jean | Director | Award | 1,884 |
| 2023-07-03 | Ros Matthew | Director | Award | 1,743 |
| 2023-06-09 | Fairmount Funds Management LLC | Director | Other | 55,500 |
| 2023-06-09 | Fairmount Funds Management LLC | Director | Other | 286,851 |
| 2023-06-09 | Fairmount Funds Management LLC | Director | Buy | 800,000 |
| 2023-06-09 | Fairmount Funds Management LLC | Director | Other | 11,914 |
| 2023-06-07 | Morris Arlene | Director | Award | 36,700 |
| 2023-06-07 | CAIN CHRISTOPHER W. | Director | Award | 36,700 |
| 2023-06-07 | Ferrante Karen Jean | Director | Award | 36,700 |
| 2023-06-07 | Shegog Todd | Director | Award | 36,700 |
| 2023-06-07 | Ros Matthew | Director | Award | 36,700 |
| 2023-06-07 | Harwin Peter Evan | Director | Award | 36,700 |
| 2023-04-03 | Ferrante Karen Jean | Director | Award | 2,053 |
| 2023-04-03 | Ros Matthew | Director | Award | 1,900 |
| 2023-02-13 | Sachs Jessica | Chief Medical Officer | Award | 160,000 |
| 2023-02-13 | Robinson John Edward | Chief Scientific Officer | Award | 160,000 |